The biology of reactive intermediates in systemic lupus erythematosus

Inducible Nitric Oxide Synthase Inhibitor SD-3651 Reduces Proteinuria in MRL/lpr Mice Deficient in the NOS2 Gene

(2016) Chinedu Njoku et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Cystamine attenuates the expressions of NOS- and TLR-associated molecules in the brain of NZB/W F1 mice

(2009) Hon-Pin Wang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Widespread expression of inducible NOS and citrulline in lupus nephritis tissues

(2009) J. J. Bollain-y-Goytia et al.   INFLAMMATION RESEARCH

Activation of Mammalian Target of Rapamycin Controls the Loss of TCR  in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation

(2009) D. R. Fernandez et al.   JOURNAL OF IMMUNOLOGY

Apolipoprotein A-I Tryptophan Substitution Leads to Resistance to Myeloperoxidase-Mediated Loss of Function

(2008) Dao-Quan Peng et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis

(2008) Hsing-Hui Li et al.   CLINICAL IMMUNOLOGY

Immunogenic Oxidized Low-density Lipoprotein/β2-glycoprotein I Complexes in the Diagnostic Management of Atherosclerosis

(2008) Luis R. Lopez et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

The chemical biology of nitric oxide: Implications in cellular signaling

(2008) Douglas D. Thomas et al.   FREE RADICAL BIOLOGY AND MEDICINE

Myeloperoxidase, modified lipoproteins, and atherogenesis: Fig. 1.

(2008) Stephen J. Nicholls et al.   JOURNAL OF LIPID RESEARCH

Post-translational modifications induced by nitric oxide (NO): Implication in cancer cells apoptosis

(2008) Lissbeth Leon et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY